Asian Markets Rally as Micron and Qualcomm AI Outlook Lifts Global Tech Stocks 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Australian Household Spending Rebounds Strongly in May as Travel and Dining Drive Consumer Growth 
Singapore Inflation Stays Muted in May as Core CPI Misses Forecasts Ahead of MAS Review 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes 
Australia Inflation Cools in May, But Core CPI Keeps RBA Rate Hike Risks Alive 
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns 
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
US Dollar Climbs to One-Year High as Fed Rate Hike Expectations Surge 
Oil Prices Drop as Middle East Supply Recovery Eases Market Concerns 
Wall Street Slides as AI Stocks Tumble Following South Korea Tech Sell-Off 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Gold Drops Below $4,000 as Strong US Dollar and Fed Rate Hike Expectations Pressure Bullion 
South Korea’s KOSPI Rebounds as Samsung and SK Hynix Lead Tech Stock Recovery 
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand 
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
